WebAlert: MultiCell Technologies Inc. Investor Conference Call Starts Today At 12 Noon ET
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies, will host a live investor conference call with a simultaneous webcast, today at 12 noon Eastern, to update investors on its key drug development programs and continued expansion of its intellectual property portfolio.